Germany Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The German pharmaceuticals market had total revenues of $83.2 billion in 2022, representing a compound annual growth rate (CAGR) of 6.5% between 2017 and 2022.
- 0
- According to in-house research, in 2022, Germany accounted for 23.5% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Germany stood at 13.9% of total health spending in 2021.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Germany pharmaceuticals market by value in 2022?
- What will be the size of the Germany pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Germany pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Germany’s pharmaceuticals market in relation to its regional counterparts?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What has been the rationale behind recent strategic partnerships?
- 8 Company Profiles
- 8.1. Novartis AG
- 8.2. F. Hoffmann-La Roche Ltd
- 8.3. Bayer AG
- 8.4. Boehringer Ingelheim GmbH
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Germany pharmaceuticals market value: $ billion, 2017-22
- Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: Germany pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Novartis AG: key facts
- Table 5: Novartis AG: Annual Financial Ratios
- Table 6: Novartis AG: Key Employees
- Table 7: Novartis AG: Key Employees Continued
- Table 8: F. Hoffmann-La Roche Ltd: key facts
- Table 9: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
- Table 10: F. Hoffmann-La Roche Ltd: Key Employees
- Table 11: Bayer AG: key facts
- Table 12: Bayer AG: Annual Financial Ratios
- Table 13: Bayer AG: Key Employees
- Table 14: Bayer AG: Key Employees Continued
- Table 15: Boehringer Ingelheim GmbH: key facts
- Table 16: Boehringer Ingelheim GmbH: Key Employees
- Table 17: Germany size of population (million), 2018-22
- Table 18: Germany gdp (constant 2005 prices, $ billion), 2018-22
- Table 19: Germany gdp (current prices, $ billion), 2018-22
- Table 20: Germany inflation, 2018-22
- Table 21: Germany consumer price index (absolute), 2018-22
- Table 22: Germany exchange rate, 2018-22
- List of Figures
- Figure 1: Germany pharmaceuticals market value: $ billion, 2017-22
- Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: Germany pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in Germany, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in Germany, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in Germany, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook